marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Inovio Pharmaceuticals Balance Sheet 2011-2024 | INO
Annual Balance Sheet Inovio Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-30.9 M | -53.1 M | -230 M | 122 M | -23.7 M | -23.8 M | -19.1 M | -57.6 M | -40.5 M | -33.7 M | -5.65 M | -17.4 M | |
Long Term Debt |
- | 16.6 M | 15.5 M | 18.7 M | 77 M | - | - | - | - | - | - | - | - |
Long Term Debt Current |
2.41 M | 2.8 M | 2.6 M | 2.33 M | 2.07 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 107 M | 8.78 M | 9.35 M | 6.51 M | 6.44 M | 6.22 M | 6.42 M | 1.9 M | 2.2 M |
Total Current Liabilities |
42.6 M | 96.9 M | 65.7 M | 41.7 M | 32 M | 35.3 M | 35.4 M | 43.8 M | 31.5 M | 14 M | 29 M | 8.38 M | 11 M |
Total Liabilities |
53.6 M | 126 M | 96.3 M | 78.6 M | 139 M | 44.1 M | 44.8 M | 50.3 M | 37.9 M | 20.2 M | 35.4 M | 10.3 M | 13.2 M |
Deferred Revenue |
- | - | - | 46.6 K | 124 K | 257 K | 1.35 M | 15.2 M | 14 M | 3.58 M | 2.01 M | 742 K | 468 K |
Retained Earnings |
-1.62 B | -1.49 B | -1.21 B | -906 M | -740 M | -620 M | -523 M | -435 M | -361 M | -332 M | -296 M | -230 M | -210 M |
Total Assets |
171 M | 349 M | 496 M | 540 M | 144 M | 131 M | 187 M | 174 M | 214 M | 132 M | 88.3 M | 45.1 M | 61.1 M |
Cash and Cash Equivalents |
14.3 M | 46.3 M | 71.1 M | 251 M | 22.2 M | 23.7 M | 23.8 M | 19.1 M | 57.6 M | 40.5 M | 33.7 M | 5.65 M | 17.4 M |
Book Value |
117 M | 222 M | 400 M | 461 M | 5.4 M | 87 M | 142 M | 123 M | 176 M | 112 M | 52.9 M | 34.9 M | 47.9 M |
Total Shareholders Equity |
117 M | 222 M | 400 M | 461 M | 3.44 M | 86.9 M | 142 M | 123 M | 176 M | 111 M | 52.5 M | 34.4 M | 47.3 M |
All numbers in USD currency
Quarterly Balance Sheet Inovio Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
10 M | 10.7 M | 11.3 M | 11 M | - | - | - | 16.6 M | 13.3 M | 14.1 M | 14.8 M | 15.5 M | 16.1 M | 16.8 M | 17.4 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 20.4 M | 20.4 M | 62.8 M | 60.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
33.5 M | 37.1 M | 34.7 M | 53.6 M | 54.9 M | 63.7 M | 67.4 M | 126 M | 125 M | 162 M | 90.4 M | 96.3 M | 82.2 M | 83.3 M | 73.3 M | 78.6 M | 78.6 M | 78.6 M | 78.6 M | 139 M | 139 M | 139 M | 139 M | 44.1 M | 44.1 M | 44.1 M | 44.1 M | 44.8 M | 44.8 M | 44.8 M | 44.8 M | 50.3 M | 50.3 M | 50.3 M | 50.3 M | 37.9 M | 37.9 M | 37.9 M | 37.9 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 35.4 M | 35.4 M | 35.4 M | 35.4 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | 8.98 M | 15.4 K | 21.6 K | 77.9 K | 109 K | 15.4 K | 46.6 K | 46.6 K | 46.6 K | 46.6 K | 92.4 K | 92.4 K | 92.4 K | 92.4 K | 224 K | 224 K | 224 K | 24.1 M | 1.18 M | 180 K | 549 K | 17.1 M | 14.8 M | 14.8 M | 14.8 M | 14.8 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 3.19 M | 3.19 M | 3.19 M | 3.19 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 353 K | 353 K | 353 K | 353 K | 79.5 K | 79.5 K | 79.5 K | 79.5 K |
Retained Earnings |
-1.71 B | -1.69 B | -1.65 B | -1.62 B | -1.6 B | -1.56 B | -1.53 B | -1.49 B | -1.43 B | -1.4 B | -1.29 B | -1.21 B | -1.1 B | -1.04 B | -961 M | -906 M | -906 M | -906 M | -906 M | -740 M | -740 M | -740 M | -740 M | -620 M | -620 M | -620 M | -620 M | -523 M | -523 M | -523 M | -523 M | -435 M | -435 M | -435 M | -435 M | -361 M | -361 M | -361 M | -361 M | -332 M | -332 M | -332 M | -332 M | -296 M | -296 M | -296 M | -296 M | -230 M | -230 M | -230 M | -230 M | -210 M | -210 M | -210 M | -210 M |
Total Assets |
107 M | 134 M | 129 M | 171 M | 193 M | 233 M | 267 M | 349 M | 392 M | 459 M | 446 M | 496 M | 536 M | 592 M | 655 M | 540 M | 540 M | 540 M | 540 M | 144 M | 144 M | 144 M | 144 M | 131 M | 131 M | 131 M | 131 M | 187 M | 187 M | 187 M | 187 M | 174 M | 174 M | 174 M | 174 M | 214 M | 214 M | 214 M | 214 M | 132 M | 132 M | 132 M | 132 M | 88.3 M | 88.3 M | 88.3 M | 88.3 M | 45.1 M | 45.1 M | 45.1 M | 45.1 M | 61.1 M | 61.1 M | 61.1 M | 61.1 M |
Cash and Cash Equivalents |
21.7 M | 34.4 M | 19.6 M | 14.3 M | 18.8 M | 52.7 M | 28.2 M | 46.3 M | 22 M | 41.1 M | 59 M | 71.1 M | 67.9 M | 58.9 M | 83.6 M | 251 M | 251 M | 251 M | 251 M | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 57.6 M | 57.6 M | 57.6 M | 57.6 M | 40.5 M | 40.5 M | 40.5 M | 40.5 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 5.65 M | 5.65 M | 5.65 M | 5.65 M | 17.4 M | 17.4 M | 17.4 M | 17.4 M |
Book Value |
73.5 M | 96.7 M | 94.4 M | 117 M | 138 M | 169 M | 199 M | 222 M | 267 M | 298 M | 355 M | 400 M | 454 M | 509 M | 582 M | 461 M | 461 M | 461 M | 461 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 87 M | 87 M | 87 M | 87 M | 142 M | 142 M | 142 M | 142 M | 123 M | 123 M | 123 M | 123 M | 176 M | 176 M | 176 M | 176 M | 112 M | 112 M | 112 M | 112 M | 52.9 M | 52.9 M | 52.9 M | 52.9 M | 34.9 M | 34.9 M | 34.9 M | 34.9 M | 47.9 M | 47.9 M | 47.9 M | 47.9 M |
Total Shareholders Equity |
73.5 M | 96.7 M | 94.4 M | 117 M | 138 M | 169 M | 199 M | 222 M | 267 M | 298 M | 355 M | 400 M | 454 M | 509 M | 582 M | 461 M | 461 M | 461 M | 461 M | 3.44 M | 3.44 M | 3.44 M | 3.44 M | 86.9 M | 86.9 M | 86.9 M | 86.9 M | 142 M | 142 M | 142 M | 142 M | 123 M | 123 M | 123 M | 123 M | 176 M | 176 M | 176 M | 176 M | 111 M | 111 M | 111 M | 111 M | 52.5 M | 52.5 M | 52.5 M | 52.5 M | 34.4 M | 34.4 M | 34.4 M | 34.4 M | 47.3 M | 47.3 M | 47.3 M | 47.3 M |
All numbers in USD currency